Prestige BioPharma Limited
950210
Rank in Stocks
#17466
Established in 2015 and based in Singapore, Prestige BioPharma Limited operates... Established in 2015 and based in Singapore, Prestige BioPharma Limited operates as a biopharmaceutical enterprise. The company's activities encompass the research, development, and commercialization of biosimilars and novel antibody therapeutics, primarily targeting the Asia Pacific market. A significant focus for Prestige BioPharma is the creation of antibody-based treatments for critical conditions such as solid tumors, pancreatic cancer, breast cancer, gastric cancer, and arthritis. Furthermore, the firm is also advancing the development of vaccines for the COVID-19 virus.
Share Price
$2.78
Last synced: 2026-11-10
Market Cap
$166.96M
Change (1 day)
-2.86%
Change (1 year)
-67.69%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Prestige BioPharma Limited (950210)
Category
Healthcare
Operating Margin for Prestige BioPharma Limited (950210)
Operating Margin as of November 2026 TTM: -359.06%
According to Prestige BioPharma Limited's latest financial reports, its current operating margin (TTM) is -359.06%. At the end of 2025 the company had an operating margin of -470.14%.
Operating Margin history for Prestige BioPharma Limited from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -359.06% | -23.63% |
| 2025 | -470.14% | -94.84% |
| 2024 | -9,111.19% | -1,524.71% |
| 2023 | 639.51% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | -210.82% | 0.00% |
| 2018 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.11% |
US
|
|
| -149.01% | -99.58% |
US
|
|
| 25.57% | -100.07% |
AU
|
|
| 31.23% | -100.09% |
BE
|
|
| 29.35% | -100.08% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Prestige BioPharma Limited's operating margin
What is Prestige BioPharma Limited's operating margin?
Prestige BioPharma Limited's operating margin is -359.06%, as of Nov 2026.
What was Prestige BioPharma Limited's operating margin in 2025?
In 2025, Prestige BioPharma Limited's operating margin was -470.14%, compared with -9,111.19% in 2024.
How has Prestige BioPharma Limited's operating margin changed since 2020?
From 2020 to 2025, Prestige BioPharma Limited's operating margin was highest in 2023 (639.51%) and lowest in 2024 (-9,111.19%).
How does Prestige BioPharma Limited's operating margin compare with similar companies?
Prestige BioPharma Limited's operating margin (-359.06%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.